The customer observed falsely elevated ca19-9 results on the architect i2000sr analzyer.
The following data was provided for a patient diagnosed with pancreatic cancer in 2011: (b)(6) previous results of less than 10, repeats 128 (obtained on instrument (b)(4)), 113 (obtained on instrument (b)(4)).
There was no impact to patient management reported.
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling and accuracy testing.
No adverse trend was identified for the customer's issue.
Labeling was reviewed and found to be adequate.
The product was not available for return.
An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.
Based on all available information and abbott diagnostics' complaint investigation, the assay performed as intended and no product deficiency was identified.
|